DaltonTx addresses this gap with a disease- and technology-agnostic platform that plugs into pharma, biotech, and CRO workflows, giving teams immediate access to AI-enabled discovery instead of building it in-house.
DaltonTx has raised €4.6M across 1 funding round from 4 investors, most recently a Seed round in Sep 2025. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-23 | Seed | €4.6M |
| IQ Capital Partners LLP,Oxford University Innovation Fund,Redalpine,Seedcamp |
| View deal → |
